Trial · NCT03029247
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Acute Challenge 1 (Day 1) | STARTED | Daprodustat | 45 | |
| Acute Challenge 1 (Day 1) | STARTED | Recombinant Human Erythropoietin | 43 | |
| Acute Challenge 1 (Day 1) | COMPLETED | Daprodustat | 45 | |
| Acute Challenge 1 (Day 1) | COMPLETED | Recombinant Human Erythropoietin | 43 | |
| Acute Challenge 1 (Day 1) | NOT COMPLETED | Daprodustat | 0 | |
| Acute Challenge 1 (Day 1) | NOT COMPLETED | Recombinant Human Erythropoietin | 0 | |
| Hgb Maintenance Phase (8 Weeks) | STARTED | Daprodustat | 45 | |
| Hgb Maintenance Phase (8 Weeks) | STARTED | Recombinant Human Erythropoietin | 43 | |
| Hgb Maintenance Phase (8 Weeks) | COMPLETED | Daprodustat | 32 | |
| Hgb Maintenance Phase (8 Weeks) | COMPLETED | Recombinant Human Erythropoietin | 36 | |
| Hgb Maintenance Phase (8 Weeks) | NOT COMPLETED | Daprodustat | 13 | |
| Hgb Maintenance Phase (8 Weeks) | NOT COMPLETED | Recombinant Human Erythropoietin | 7 | |
| Acute Challenge 2 (Day 57) | STARTED | Daprodustat | 32 | |
| Acute Challenge 2 (Day 57) | STARTED | Recombinant Human Erythropoietin | 36 | |
| Acute Challenge 2 (Day 57) | COMPLETED | Daprodustat | 32 | |
| Acute Challenge 2 (Day 57) | COMPLETED | Recombinant Human Erythropoietin | 36 | |
| Acute Challenge 2 (Day 57) | NOT COMPLETED | Daprodustat | 0 | |
| Acute Challenge 2 (Day 57) | NOT COMPLETED | Recombinant Human Erythropoietin | 0 | |
| Follow-up Period (14 Days) | STARTED | Daprodustat | 32 | |
| Follow-up Period (14 Days) | STARTED | Recombinant Human Erythropoietin | 36 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03029247/flow